| Denisse Burgos-jimenez, | |
|
56 Franklin St, Waterbury, CT 06706 | |
| (860) 989-6067 | |
| Not Available |
| Full Name | Denisse Burgos-jimenez |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 8 Years |
| Location | 56 Franklin St, Waterbury, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013455351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 3767 (Connecticut) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 3767 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Mary's Hospital | Waterbury, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hartford Healthcare Urgent Care Centers Llc | 7618242777 | 134 |
News Archive
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Virginia Tech Carilion Research Institute scientists have shown that mutations in specific genes that destroy motor neurons and thereby cause the devastating effects of amyotrophic lateral sclerosis- also known as ALS or Lou Gehrig's disease - also attack sensory neurons.
SARS-CoV-2 is the causative agent of COVID-19 disease, currently raging across the world. The virus has now infected more than 43.89 million individuals and claimed over 1.16 million lives. The study titled, "Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects," is released on the preprint server bioRxiv* in October 2020.
Researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver- Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer.
Life Technologies, a provider of innovative life science solutions, announced at the International Association of Food Protection annual meeting the launch of the MicroSEQ E. coli O157:H7 assay, designed to detect the deadly strain of Escherichia coli (E. coli), using the company's industry-leading real-time PCR technology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Denisse Burgos-jimenez, 841 New Britain Ave, Hartford, CT 06106-3920 Ph: () - | Denisse Burgos-jimenez, 56 Franklin St, Waterbury, CT 06706 Ph: (860) 989-6067 |
News Archive
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Virginia Tech Carilion Research Institute scientists have shown that mutations in specific genes that destroy motor neurons and thereby cause the devastating effects of amyotrophic lateral sclerosis- also known as ALS or Lou Gehrig's disease - also attack sensory neurons.
SARS-CoV-2 is the causative agent of COVID-19 disease, currently raging across the world. The virus has now infected more than 43.89 million individuals and claimed over 1.16 million lives. The study titled, "Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects," is released on the preprint server bioRxiv* in October 2020.
Researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center have made significant strides in the study of a primary cancer of the liver- Intrahepatic Cholangiocarcinoma (IHCC), also called biliary tract cancer.
Life Technologies, a provider of innovative life science solutions, announced at the International Association of Food Protection annual meeting the launch of the MicroSEQ E. coli O157:H7 assay, designed to detect the deadly strain of Escherichia coli (E. coli), using the company's industry-leading real-time PCR technology.
› Verified 5 days ago
Ms. Jodi Lasky, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 26 Westport Dr, Waterbury, CT 06706 Phone: 203-565-4728 | |
Jaclyn M Sylvia, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 60 Westwood Ave, Suite 104, Waterbury, CT 06708 Phone: 203-574-5997 Fax: 203-574-5987 | |
Mrs. Juliet Elisabeth Rivera, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 64 Robbins St, Waterbury, CT 06708 Phone: 203-573-7066 | |
Anxhela Kulla, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1981 E Main St Unit 2, Waterbury, CT 06705 Phone: 203-709-5520 | |
Dylan Stempel, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 56 Franklin St, Waterbury, CT 06706 Phone: 860-227-4756 | |
Lynn Baylis, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 64 Robbins St, Waterbury, CT 06708 Phone: 203-573-6295 Fax: 203-573-7613 |